Literature DB >> 17001619

Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations.

Joy C Bunt1, Jonathan Krakoff, Emilio Ortega, William C Knowler, Clifton Bogardus.   

Abstract

BACKGROUND: Earlier prospective studies have identified insulin action and secretion as predictors of T2DM in populations with normal glucose tolerance (NGT) and impaired glucose tolerance (IGT) (2-h OGTT < 7.8 and 7.8-11 mmol/L, respectively). Fasting plasma glucose (FPG), an additional and recently modified (normal <5.6 mmol/L) diagnostic criterion is associated with insulin secretion. We wanted to establish whether insulin secretion persists as an independent predictor of T2DM in individuals with no clinical evidence of impaired glucose regulation based on FPG and 2-h plasma glucose concentrations.
METHODS: Insulin action (M, euglycemic-hyperinsulinemic clamp), insulin secretion (acute insulin response (AIR), IVGTT), and adiposity (%Fat, DXA or densitometry) were compared at baseline in 358 Pima Indians (232M/126F, 18-44 years old) with normal glucose regulation of whom 61 (35M/26F) developed diabetes (DIAB) during a median follow-up time of 7.6 years.
RESULTS: In proportional-hazard analysis, % Fat (HR = 1.52, p = 0.03), M (HR = 0.51, p = 0.04) and AIR (HR = 0.64, p = 0.003) predicted the development of diabetes after adjustment for age and sex. In regression analysis adjusting for age, sex, %Fat and M at baseline, the non-diabetic group (NON-DM) had a higher AIR (p = 0.0002) than the DIAB group; the positive association of AIR with adiposity observed in the NON-DM group was absent in the DIAB group. Cumulative incidence rates (12y) for diabetes were highest (48%) in subjects with both M and AIR below the population median and lowest (11%) in subjects with both M and AIR above the population median.
CONCLUSION: AIR can predict diabetes prior to the current clinical indicators of impaired glucose regulation. Published in 2006 by John Wiley & Sons, Ltd. John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17001619      PMCID: PMC2128254          DOI: 10.1002/dmrr.686

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  38 in total

1.  Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.

Authors:  C Weyer; J E Foley; C Bogardus; P A Tataranni; R E Pratley
Journal:  Diabetologia       Date:  2000-12       Impact factor: 10.122

2.  Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes.

Authors:  J F Gautier; C Wilson; C Weyer; D Mott; W C Knowler; M Cavaghan; K S Polonsky; C Bogardus; R E Pratley
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

Review 3.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

Authors:  R A DeFronzo
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

4.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

Authors:  F de Vegt; J M Dekker; A Jager; E Hienkens; P J Kostense; C D Stehouwer; G Nijpels; L M Bouter; R J Heine
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

5.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

6.  Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

Authors:  C Weyer; T Funahashi; S Tanaka; K Hotta; Y Matsuzawa; R E Pratley; P A Tataranni
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

8.  The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.

Authors:  James B Meigs; Denis C Muller; David M Nathan; Deirdre R Blake; Reubin Andres
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

9.  Adiponectin and development of type 2 diabetes in the Pima Indian population.

Authors:  Robert S Lindsay; Tohru Funahashi; Robert L Hanson; Yuji Matsuzawa; Sachiyo Tanaka; P Antonio Tataranni; William C Knowler; Jonathan Krakoff
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

10.  Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.

Authors:  S P O'Rahilly; Z Nugent; A S Rudenski; J P Hosker; M A Burnett; P Darling; R C Turner
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

View more
  23 in total

1.  Impact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose tolerance.

Authors:  Gang Chen; Meizhi Li; Yuan Xu; Nianhui Chen; Huibin Huang; Jixing Liang; Liantao Li; Junping Wen; Lixiang Lin; Jin Yao
Journal:  Diabetes Technol Ther       Date:  2012-03-09       Impact factor: 6.118

2.  One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans.

Authors:  Ethan Paddock; Maximilian G Hohenadel; Paolo Piaggi; Pavithra Vijayakumar; Robert L Hanson; William C Knowler; Jonathan Krakoff; Douglas C Chang
Journal:  Diabetologia       Date:  2017-06-29       Impact factor: 10.122

3.  Prevalence of insulin resistance and its relationship with cardiovascular disease risk factors among Thai adults over 35 years old.

Authors:  Hau D Do; Vitool Lohsoonthorn; Wiroj Jiamjarasrangsi; Somrat Lertmaharit; Michelle A Williams
Journal:  Diabetes Res Clin Pract       Date:  2010-05-13       Impact factor: 5.602

4.  The correlation between the oral glucose tolerance test 30-minutes plasma glucose and risk factors for diabetes and cardiovascular diseases: a cross-sectional epidemiological study of diabetes in Fujian Province in the South-East of China.

Authors:  G Chen; X Zou; J Yao; Q Jiang; Y Zhang; M Tu; S Yang; S Xu; W Lin; H Huang; J Liang; L Li; L Lin
Journal:  J Endocrinol Invest       Date:  2010-10-08       Impact factor: 4.256

5.  Validating a dimensionless number for glucose homeostasis in humans.

Authors:  David J Klinke
Journal:  Ann Biomed Eng       Date:  2009-06-10       Impact factor: 3.934

6.  Adipose tissue and serum CCDC80 in obesity and its association with related metabolic disease.

Authors:  O Osorio-Conles; M Guitart; J M Moreno-Navarrete; X Escoté; X Duran; J M Fernandez-Real; A M Gomez-Foix; S Fernández-Veledo; J Vendrell
Journal:  Mol Med       Date:  2017-08-23       Impact factor: 6.354

7.  Serum uric acid predicts both current and future components of the metabolic syndrome.

Authors:  Kristy Osgood; Jonathan Krakoff; Marie Thearle
Journal:  Metab Syndr Relat Disord       Date:  2013-01-29       Impact factor: 1.894

8.  DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients.

Authors:  Michael Volkmar; Sarah Dedeurwaerder; Daniel A Cunha; Matladi N Ndlovu; Matthieu Defrance; Rachel Deplus; Emilie Calonne; Ute Volkmar; Mariana Igoillo-Esteve; Najib Naamane; Silvia Del Guerra; Matilde Masini; Marco Bugliani; Piero Marchetti; Miriam Cnop; Decio L Eizirik; François Fuks
Journal:  EMBO J       Date:  2012-01-31       Impact factor: 11.598

9.  Childhood predictors of adult acute insulin response and insulin action.

Authors:  Marie S Thearle; Joy C Bunt; William C Knowler; Jonathan Krakoff
Journal:  Diabetes Care       Date:  2009-02-19       Impact factor: 17.152

10.  Role of Established Type 2 Diabetes-Susceptibility Genetic Variants in a High Prevalence American Indian Population.

Authors:  Robert L Hanson; Rong Rong; Sayuko Kobes; Yunhua Li Muller; E Jennifer Weil; Jeffrey M Curtis; Robert G Nelson; Leslie J Baier
Journal:  Diabetes       Date:  2015-02-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.